Abstract
The availability of easily accessible biochemical trait markers of central cholinergic activity would assist in the identification of homogeneous subgroups of neuropsychiatric patients within specific diagnostic categories. In addition to a refinement of nosology, these measures could also help to design specific treatment interventions. The activities of cholinesterase isoenzymes in blood have been reported to be abnormal in neuropsychiatric disorders with proven or hypothesized abnormalities of central cholinergic transmission. However, the relevance of these peripheral cholinesterase abnormalities to disordered central cholinergic transmission remains uncertain. Future studies examining specific cholinesterase isoenzymes in homogeneous diagnostic groups are needed to determine the potential utility of these measures as peripheral trait markers of central cholinergic activity.
Similar content being viewed by others
References
Davis, K. L., andBerger, P. A. 1978. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Biol. Psychiat. 13:23–49.
Davis, K. L. 1979. Cholinomimetic treatment of neuropsychiatric disorders: a review of recent developments. Mt. Sinai J. Med. 46:455–459.
Davies, P., andMaloney, A. J. F. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., andDeLong, M. R. 1981. Alzheimer disease: evidence for selectived loss of cholinergic neurons in the nucleus basalis. Ann. Neurology 10:122–126.
Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T., andDeLong, M. R. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239.
Johns, C. A., Greenwald, B. S., Mohs, R. C., andDavis, K. L. 1983. The cholinergic treatment strategy in aging and senile dementia. Psychopharm. Bull. 19:185–197.
Janowsky, D. S., El-Yousef, M. K., Davis, J. M., andSekerke, H. J. 1972. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632–635.
Stahl, S. M., andBerger, P. A. 1982. Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiency. Biol. Psychiat. 17:1047–1053.
Milstoc, M., Teodoru, C. V., Fieve, R. R., andKumbaraci, T. 1975. Cholinesterase activity and the manic-depressive patients. Dis. of the Nerv. System 36:197–199.
Chipperfield, B., Newman, P. M., andMoyes, I. C. A. 1981. Decreased erythrocyte cholinesterase activity in dementia. Lancet 1:199.
Perry, E. K., Perry, R. H., Blessed, G., andTomlinson, B. E. 1978. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropath. Appl. Neurobiol. 4:273–277.
Deutsch, S. I., Mohs, R. C., andDavis, K. L. 1982. A rationale for studying the transmissibility of Alzheimer's disease. Neurobiol. Aging 3:145–147.
Perry, R. H., Wilson, I. D., Bober, M. J., Atack, J., Blessed, G., Tomlinson, B. E., andPerry, E. K. 1982. Plasma and erythrocyte acetylycholinesterase in senile dementia of Alzheimer type. Lancet 2:174–175.
Smith, R. C., Ho, B. T., Hsu, L., Vroulis, G. A., Glaghorn, J., andSchoolar, J. 1982. Cholinesterase enzymes in the blood of patients with Alzheimer's disease. Life Sci. 30:543–546.
Deutsch, S. I., Mohs, R. C., Levy, M. I., Rothpearl, A. B., Stockton, D., Horvath, T., Coco, A., andDavis, K. L. 1983. Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals. Biol. Psychiatr. 18:1363–1373.
Mathew, R. J., Ho, B. T., Khan, M. M., Perales, C., Weinan, M. L., andClaghorn, J. L. 1982. True and pseudocholinesterases in depression. Am. J. Psychiat. 139:125–127.
Fieve, R. R., Milstoc, M., Kumbaraci, T., andDunner, D. L. 1976. The effect of lithium on red blood cell cholinesterase activity in patients with affective disorders. Dis. Nerv. System 37:240–243.
Domino, E. F., andKrause, R. R. 1972. Reexamination of red cell and plasma cholinesterase activity in drug-free chronic schizophrenic patients and normals. Biol. Psychiatr. 4:17–31.
Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III), 1980, American Psychiatric Association, Washington, D.C.
Lucas, A. R., Krause, R. R., andDomino, E. F. 1971. Biological studies in childhood schizophrenia: plasma and RBC cholinesterase activity. J. Autism Child. Schiz. 1:72–81.
Bender, L. 1947. Childhood schizophrenia: clinical study of one hundred schizophrenic children. Am. J. Orthopsychiat. 17:40–56.
Rabinovitch, R. D., Lucas, A. R., andIngram, W. 1965. Childhood schizophrenia: Evolution to adulthood. Paper presented at American Orthopsychiatric Association Annual Meeting, New York, March 1965.
Young, J. G., Kavanagh, M. E., Anderson, G. M., Shaywitz, B. A., andCohen, D. J. 1982. Clinical neurochemistry of autism and associated disorders. J. Autism Dev. Disorders 12:147–165.
Festoff, B. W., andFernandez, H. L. 1981. Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis. Muscle & Nerve 4:41–47.
Deutsch, S. I., andDavis, K. L. 1983. Schizophrenia: A review of diagnostic and biological issues. I. Diagnosis and Prognosis. Hosp. Community Psychiat. 34:313–322.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deutsch, S.I., Campbell, M. Status of cholinesterase activities in blood in neuropsychiatric disorders. Neurochem Res 9, 863–869 (1984). https://doi.org/10.1007/BF00964519
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964519